00:00 / 00:00
Type I hypersensitivity
Autoimmune hemolytic anemia
Hemolytic disease of the newborn
Rheumatic heart disease
Type II hypersensitivity
Systemic lupus erythematosus
Type III hypersensitivity
Type IV hypersensitivity
Common variable immunodeficiency
Hyperimmunoglobulin E syndrome
IgG subclass deficiency
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
Adenosine deaminase deficiency
Hyper IgM syndrome
Severe combined immunodeficiency
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Chronic granulomatous disease
Leukocyte adhesion deficiency
Blood transfusion reactions and transplant rejection: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
0 / 8 complete
0 / 1 complete
Combined B & T-Cell Disorders
ataxia-telangiectasia p. 115
ataxia-telangiectasia p. 38
With ataxia telangiectasia, ataxia refers to poor coordination and telangiectasia refers to dilated blood vessels, which are the two key symptoms of this disease.
Ataxia telangiectasia develops when a genetic mutation causes the lack of a protein called ataxia telangiectasia mutated serine-threonine kinase, or just ATM for short, which normally fixes up damaged DNA.
DNA of every cell gets damaged over and over again from various environmental factors like radiation and chemical toxins.
Now, one of the most severe types DNA damage is a double-strand break, where both strands of the DNA’s double helix are severed, damaging the genetic information that was stored there. To help with this sort of repair, there’s a protein called ATM.
ATM is primarily located in the cell's nucleus, and you can sort of think of ATM as like a manager of the DNA’s repair.
It’s protein kinase, which means that it uses it’s managing skills to activate other proteins through phosphorylation, which is the addition of a phosphoryl or -PO32− group.
So at the site of the double strand break, ATM phosphorylates proteins like the tumor suppressor protein p53, that stop the cell from reproducing.
ATM also phosphorylates additional proteins which will either fix the DNA or kill the faulty cell through a process of apoptosis - controlled cell death. This way we don't end up with a bunch of defective cells trying to reproduce.
That's the main role of ATM, but it also plays a role in the development of immune cells, especially T lymphocytes.
T lymphocytes need to be able to recognize a wide variety of antigens, and to do this, they purposefully create double strand breaks in their DNA during development. That way parts of their DNA can get rearranged, and code for new and unique antigen receptors.
Once again, ATM helps to fix these breaks - and that keeps the T-cells functioning normally.
In ataxia telangiectasia, there's an autosomal recessive mutation of the ATM gene.
This leads to a decrease in the amount of functioning ATM protein, and as a result, cells that undergo a double-strand break don't have sufficient ATM to repair the break.
As a result, some of the damaged cells might survive and continue to proliferate despite the damage, but most ultimately die off.
Ataxia-telangiectasia (A-T) also called Louis-Bar Syndrome, is an autosomal recessive condition characterized by progressive cerebellar atrophy and oculocutaneous telangiectasia (small dilated vessels under the skin). People with A-T often have high rates of cancer and immunodeficiency disorders. It is caused by a mutation of the ataxia telangiectasia mutated (ATM) gene, and it is characterized by poor muscle coordination or ataxia (often needing a wheelchair by the age of 10), dysarthria, and telangiectasia on the skin and eyes.
Latest on COVID-19
Nurse Practitioner (NP)
Physician Assistant (PA)
Create custom content
Raise the Line Podcast
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
Terms and Conditions
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.